Likewise, when engineered vaults packaged with CCL21-INT (CCL21 being a chemokine able to attract a variety of immune cells) were delivered intratumorally into murine tumor models—i.e., either Lewis Lung tumor [213] or glioma [214]; this resulted in a substantial growth inhibition. This evidence concerns the gene CCL21 and neoplasm.